Morgan Stanley Upgrades Roche to Overweight, Boosts PT

MT Newswires · 1d ago
08:35 AM EDT, 08/07/2026 (MT Newswires) -- Morgan Stanley on Thursday raised Swiss pharmaceutical group Roche (RO.SW) to overweight from equal weight and increased its price target to 410 francs from 295 francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)